Skip to main content
NIH funding notice PAR-23-041

Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)

Closed on August 6, 2024.

Posted
November 1, 2022
Close date
August 6, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $578,665 in first-year total cost, median $191,521.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 DRO-N (O1)]1
  2. Special Emphasis Panel[ZDA1 IXR-N (J1)]1
  3. Special Emphasis Panel[ZDA1 IXR-N (O1)]1

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
  2. UNIVERSITY OF UTAH1
  3. WAKE FOREST UNIVERSITY HEALTH SCIENCES1
Competing awards under PAR-23-041 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025In vivo massive parallel reporter assay to analyze the function of cis-regulatory elements and variants implicated in substance use disorders1R21DA060455-01A1BENNER, CHRISTOPHER WHEINZ, SVEN WTELESE, FRANCESCAUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$197,500ZDA1
2024Genetics of Amphetamine Preference1R21DA060453-01ROTHENFLUH, ADRIANUNIVERSITY OF UTAH, UT$191,521ZDA1
2024Drd3 transcript variants and cocaine self-administration1R21DA059919-01CHEN, RONGWAKE FOREST UNIVERSITY HEALTH SCIENCES, NC$189,644ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-23-041: Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) | ScienceDex | ConductScience